Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Ng

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cell Reports|September 22, 2021
Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodesTeruyuki Sano, Takahiro Kageyama, Victoria Fang, et al.
Plos One|December 24, 2011
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathwayMohammad Atefi, Erika von Euw, Narsis Attar, et al.
Journal of Translational Medicine|May 26, 2011
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutationsFranziska Niehr, Erika von Euw, Narsis Attar, et al.
Cancer Discovery|November 23, 2013
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibitionHubing Shi, Aayoung Hong, Xiangju Kong, et al.
Molecular Cancer|April 21, 2012
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell linesErika von Euw, Mohammad Atefi, Narsis Attar, et al.
Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.
Molecular Oncology|December 19, 2013
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitorsHelena Escuin-Ordinas, Mohammad Atefi, Yong Fu, et al.
Nature|April 18, 2014
Focused specificity of intestinal TH17 cells towards commensal bacterial antigensYi Yang, Miriam B Torchinsky, Michael Gobert, et al.
Nature Communications|March 8, 2012
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistanceHubing Shi, Gatien Moriceau, Xiangju Kong, et al.
Journal of the American Heart Association|December 7, 2021
Clinicians for CARE: A Systematic Review and Meta-Analysis of Interventions to Support Caregivers of Patients With Heart DiseaseKellen A Knowles, Helen Xun, Sunyoung Jang, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cell Reports|September 22, 2021
Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodesTeruyuki Sano, Takahiro Kageyama, Victoria Fang, et al.
Plos One|December 24, 2011
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathwayMohammad Atefi, Erika von Euw, Narsis Attar, et al.
Journal of Translational Medicine|May 26, 2011
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutationsFranziska Niehr, Erika von Euw, Narsis Attar, et al.
Cancer Discovery|November 23, 2013
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibitionHubing Shi, Aayoung Hong, Xiangju Kong, et al.
Molecular Cancer|April 21, 2012
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell linesErika von Euw, Mohammad Atefi, Narsis Attar, et al.
Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.
Molecular Oncology|December 19, 2013
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitorsHelena Escuin-Ordinas, Mohammad Atefi, Yong Fu, et al.
Nature|April 18, 2014
Focused specificity of intestinal TH17 cells towards commensal bacterial antigensYi Yang, Miriam B Torchinsky, Michael Gobert, et al.
Nature Communications|March 8, 2012
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistanceHubing Shi, Gatien Moriceau, Xiangju Kong, et al.
Journal of the American Heart Association|December 7, 2021
Clinicians for CARE: A Systematic Review and Meta-Analysis of Interventions to Support Caregivers of Patients With Heart DiseaseKellen A Knowles, Helen Xun, Sunyoung Jang, et al.
Pageof 5